BioXcel Therapeutics, Inc. — SC 13G/A Filings
18 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by BioXcel Therapeutics, Inc. (BTAI), sorted by most recent first. Each row links to the full filing on EdgarLookup. BioXcel Therapeutics, Inc. has filed 18 SC 13G/A documents with the SEC since 2017. To view all SEC filings by BioXcel Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
144/A
3
3/A
4
4/A
424B4
424B5
424B7
5
8-A12B
8-K
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEL AM
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POSASR
PRE 14A
RW
RW WD
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0000315066-24-001972 | Sep 10, 2024 | — |
| SC 13G/A | — | 0000315066-24-000974 | Feb 9, 2024 | — |
| SC 13G/A | BIOXCEL THERAPEUTICS, INC. | 0000902664-24-001152 | Feb 7, 2024 | — |
| SC 13G/A | SC 13G/A | 0001019056-23-000371 | Oct 19, 2023 | — |
| SC 13G/A | — | 0000315066-23-002712 | Oct 13, 2023 | — |
| SC 13G/A | SC 13G/A | 0001019056-23-000197 | Apr 4, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-021748 | Feb 14, 2023 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0001532155-23-000066 | Feb 14, 2023 | — |
| SC 13G/A | — | 0001306550-23-008485 | Feb 9, 2023 | — |
| SC 13G/A | — | 0000315066-23-001431 | Feb 9, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-023064 | Feb 14, 2022 | — |
| SC 13G/A | — | 0000315066-22-000826 | Feb 9, 2022 | — |
| SC 13G/A | — | 0000315066-21-001630 | Jul 12, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-024376 | Feb 16, 2021 | — |
| SC 13G/A | — | 0000315066-21-000877 | Feb 8, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-061005 | May 14, 2020 | — |
| SC 13G/A | — | 0000315066-20-000854 | Feb 7, 2020 | — |
| SC 13G/A | — | 0000315066-19-000020 | Jan 10, 2019 | — |